Kim specialises in intellectual property law, with a focus on patents and regulation of pharmaceuticals, biotech and health related products and services.
Kim acts for a wide range of clients in commercialising intellectual property and in resolving disputes. She also advises on day to day activities, including commercial transactions, joint ventures, marketing and distribution arrangements, research and development, labelling and advertising. She assists clients to navigate complex regulatory requirements and to resolve issues encountered in achieving regulatory approval.
Kim's experience includes:
- acting for a range of pharmaceutical and biotech companies, providing strategic advice, registration and listing of pharmaceuticals, dealing with the Pharmaceutical Benefits Advisory Committee and the Pharmaceutical Benefits Pricing Authority, competition law matters in relation to pharmaceuticals and matters generally relating to the Pharmaceutical Benefits Scheme and Part VII of the National Health Act and other regulatory oversight of the pharmaceuticals industry (including the Therapeutic Goods Act), prepared clinical trial agreements and advised on issues arising in relation to trials.
- representing clients in regulatory investigations, inquiries and Royal Commissions - leveraging her experience in complex disputes to counsel clients through the life-cycle of regulatory interventions. Her practice includes advising clients in relation to the approval and listing of medicines and medical devices, therapeutic goods compliance, product safety, and appeals from administrative decisions, particularly in relation to medical, healthcare and scientific issues.
- handling matters involving patents in a range of technologies, such as telecommunications, financial systems, banking and payments and internet security. She has also conducted litigation involving inventions in other technological fields, including food products, methods of treatment, genetically modified plants, plastics, plumbing valves, mining, explosives, railways, telecommunications, and numerous medical devices.
